Apeng Yang

2PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 15, 2026
Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

|Aug 11, 2026
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study.

Pageof 1

Frequent Collaborators

2 joint publications

Zhiyong Zeng

1 joint publications

Ruixian Xing

1 joint publications

Juan Huang

1 joint publications

Liang Wang